Depression News and Research

Latest Depression News and Research

Metanx promotes restoration of lost cutaneous sensation in Diabetic Neuropathy patients

PamLab L.L.C., developer and marketer of Metanx®, announced today that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases. The study demonstrated that Metanx®, a medical food available by prescription, promotes restoration of lost cutaneous sensation in DN patients.

27 Jan 2011

War-time stress may lead to increased risk of death by coronary heart disease in later life

War-time stress may lead to an increased risk death by coronary heart disease in later life. Researchers writing in BioMed Central's open access journal BMC Health Services Research surveyed a cohort of 55 year old Finnish WW2 veterans in 1980, and then carried out a follow-up study 28 years later.

27 Jan 2011

Nexstim closes additional equity financing for approximately EUR 11.4 million

Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.

27 Jan 2011

Study: Low SES is linked to high risk of depression in patients with RA

Physical and Mental Health Disparities Found in Those with Low Socioeconomic Position. A recent study confirmed that low socioeconomic status is associated with higher risk of depressive symptoms in patients with rheumatoid arthritis.

26 Jan 2011

Mental health laws delayed to take into account public opinion

The Victorian government has extended the closing date for public comment on changes to the state’s Mental Health Act. The deadline has been extended to February 28. Submissions on the Exposure Draft Mental Health Bill 2010 can be lodged online.

26 Jan 2011

Arizona State University sponsored forum addresses child health crises in America

Richard Carmona, MD, MPH, FACS, 17th Surgeon General of the U.S. (2002-2006), said there is "no choice but to act" today to find solutions to the child obesity epidemic and mental health problems in the nation at a forum attended by more than 200 health leaders at the National Press Club. Dr. Carmona made his remarks at "America's Children at Peril: Solving the Child Obesity and Mental Health Epidemics," a forum sponsored by Arizona State University and its College of Nursing & Health Innovation.

25 Jan 2011

Composer Fr-d-ric Chopin probably had temporal lobe epilepsy

The composer Fr-d-ric Chopin, who regularly hallucinated, probably had temporal lobe epilepsy throughout his short life, reveals research published online in Medical Humanities. Hallucinations typically feature in seizure disorders, they say.

25 Jan 2011

Patients with chronic depression can benefit from pioneering neurosurgical treatment

Pioneering neurosurgical treatment, a world first in Bristol, which very accurately targets brain networks involved in depression, could help people who suffer with severe and intractable depression.

25 Jan 2011

Chiropractic treatment helps female Army Brigadier General to battle against fibromyalgia

After 27 years of service, decorated U.S. Army Brigadier General Becky Halstead (Retired), the first female West Point graduate in U.S. history to command at the strategic level in Iraq and Afghanistan, decided to retire after being diagnosed with fibromyalgia - a medically unexplained syndrome affecting the muscles and connective tissues.

25 Jan 2011

Weighty matters

The Dieticians Association of Australia (DAA) has launched the “Healthy Weight Week”. The DAA says that 61 per cent of Australian adults and 25 per cent of Australian children are either overweight or obese. At present there are really no drugs that provide long term weight loss. The only resort is surgery.

24 Jan 2011

Healthcare workers can help improve quality of life for end of life patients

Healthcare workers can most directly affect quality of life (QOL) of patients with advanced stage lung cancer by helping manage symptoms such as pain, lack of energy, shortness of breath, coughing, difficulty sleeping and dry mouth, according to a study recently published in the journal Oncology Nursing Forum.

24 Jan 2011

FDA approves Clinical Data's Viibryd for major depressive disorder

Clinical Data, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved vilazodone HCl tablets, to be marketed under the brand name Viibryd™, for the treatment of adults with major depressive disorder (MDD).

24 Jan 2011

PGxHealth receives FDA approval for Viibryd tablets to treat major depressive disorder

The U.S. Food and Drug Administration today approved Viibryd tablets (vilazodone hydrochloride) to treat major depressive disorder in adults.

24 Jan 2011

$Medicare reimbursed for only a fraction of the services recommended by government task force, study finds$

Medicare reimbursed for only a fraction of the services recommended by government task force, study finds

Health care reform should be able to mend a disconnect that has existed between the recommendations of the U.S. Preventive Services Task Force (USPSTF), a task force charged by the government to review clinical preventive health services for older adults, and Medicare coverage for those services, a new UCLA-led study finds.

21 Jan 2011

MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium

The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE, a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder.

21 Jan 2011

Health Canada approves Labopharm's OLEPTRO for treatment of Major Depressive Disorder

Labopharm Inc. today announced that Health Canada's Therapeutic Products Directorate (TPD) has approved OLEPTRO, a novel once-daily formulation of the antidepressant trazodone, for the symptomatic relief of Major Depressive Disorder in adults.

21 Jan 2011

Preliminary top-line results from levomilnacipran Phase III study for MDD

Forest Laboratories, and Pierre Fabre Medicament today announced preliminary top-line results from a Phase III study of levomilnacipran for the treatment of major depressive disorder.

20 Jan 2011

Brains of migraine sufferers show higher proportion of lesions of brain microvessels

Recent work, in particular the CAMERA study, has used MRI to study the brains of migraine sufferers and has shown that a higher proportion of these patients exhibit lesions of the brain microvessels than the rest of the population.

20 Jan 2011

Takeda Cambridge, Evotec enter collaboration to identify novel modulators against GPCR

Evotec AG today announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule modulators against GPCR and Protease targets involved in various CNS and Metabolic diseases.

20 Jan 2011

Singapore study finds video game addiction exists globally

A new study by an international research team -- including an Iowa State University psychologist -- found further evidence that video game "addiction" exists globally and that greater amounts of gaming, lower social competence and greater impulsivity were risk factors for becoming pathological gamers.

20 Jan 2011

Depression News and Research

Latest Depression News and Research

Metanx promotes restoration of lost cutaneous sensation in Diabetic Neuropathy patients

War-time stress may lead to increased risk of death by coronary heart disease in later life

Nexstim closes additional equity financing for approximately EUR 11.4 million

Study: Low SES is linked to high risk of depression in patients with RA

Mental health laws delayed to take into account public opinion

Arizona State University sponsored forum addresses child health crises in America

Composer Fr-d-ric Chopin probably had temporal lobe epilepsy

Patients with chronic depression can benefit from pioneering neurosurgical treatment

Chiropractic treatment helps female Army Brigadier General to battle against fibromyalgia

Weighty matters

Healthcare workers can help improve quality of life for end of life patients

FDA approves Clinical Data's Viibryd for major depressive disorder

PGxHealth receives FDA approval for Viibryd tablets to treat major depressive disorder

Medicare reimbursed for only a fraction of the services recommended by government task force, study finds

MGH Bipolar CHOICE trial to evaluate effectiveness of new medications compared to lithium

Health Canada approves Labopharm's OLEPTRO for treatment of Major Depressive Disorder

Preliminary top-line results from levomilnacipran Phase III study for MDD

Brains of migraine sufferers show higher proportion of lesions of brain microvessels

Takeda Cambridge, Evotec enter collaboration to identify novel modulators against GPCR

Singapore study finds video game addiction exists globally

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in